81 FR 15568 - Importer of Controlled Substances Registration: Cerilliant Corporation
DEPARTMENT OF JUSTICE
Drug Enforcement Administration Federal Register Volume 81, Issue 56 (March 23, 2016)
Drug Enforcement Administration
Federal Register Volume 81, Issue 56 (March 23, 2016)
| Page Range | 15568-15571 | |
| FR Document | 2016-06548 |
[Federal Register Volume 81, Number 56 (Wednesday, March 23, 2016)] [Notices] [Pages 15568-15571] From the Federal Register Online [www.thefederalregister.org] [FR Doc No: 2016-06548] ----------------------------------------------------------------------- DEPARTMENT OF JUSTICE Drug Enforcement Administration [Docket No. DEA-392] Importer of Controlled Substances Registration: Cerilliant Corporation ACTION: Notice of registration. ----------------------------------------------------------------------- SUMMARY: Cerilliant Corporation applied to be registered as an importer of certain basic classes of controlled substances. The Drug Enforcement Administration (DEA) grants Cerilliant Corporation registration as an importer of those controlled substances. SUPPLEMENTARY INFORMATION: By notice dated October 13, 2015, and published in the Federal Register on October 21, 2015, 80 FR 63836, Cerilliant Corporation, 811 Paloma Drive, Suite A, Round Rock, Texas 78665-2402 applied to be registered as an importer of certain basic classes of controlled substances. Comments and requests for hearing on applications to import narcotic raw material are not appropriate. 72 FR 3417, (January 25, 2007). No comments or objections were submitted for this notice. The DEA has considered the factors in 21 U.S.C. 823, 952(a) and 958(a) and determined that the registration of Cerilliant Corporation to import the basic classes of controlled substances is consistent with the public interest and with United States obligations under international treaties, conventions, or protocols in effect on May 1, 1971. The DEA investigated the company's maintenance of effective controls against diversion by inspecting and testing the company's physical security systems, verifying the company's compliance with state and local laws, and reviewing the company's background and history. Therefore, pursuant to 21 U.S.C. 952(a) and 958(a), and in accordance with 21 CFR 1301.34, the above-named company is granted registration as an importer of the following basic classes of controlled substances: ------------------------------------------------------------------------ Controlled substance Schedule ------------------------------------------------------------------------ 3-Fluoro-N-methylcathinone (3-FMC) (1233)... I Cathinone (1235)............................ I Methcathinone (1237)........................ I 4-Fluoro-N-methylcathinone (4-FMC) (1238)... I Pentedrone (a-methylaminovalerophenone) I (1246). Mephedrone (4-Methyl-N-methylcathinone) I (1248). 4-Methyl-N-ethylcathinone (4-MEC) (1249).... I Naphyrone (1258)............................ I N-Ethylamphetamine (1475)................... I N,N-Dimethylamphetamine (1480).............. I Fenethylline (1503)......................... I Methaqualone (2565)......................... I JWH-250 (1-Pentyl-3-(2- I methoxyphenylacetyl)indole) (6250). SR-18 (Also known as RCS-8) (1- I Cyclohexylethyl-3-(2- methoxyphenylacetyl)indole) (7008). [[Page 15569]] 5-Flouro-UR-144 and XLR11 [1-(5-Fluoro- I pentyl)1H-indol-3-yl](2,2,3,3- tetramethylcyclopropyl)methanone (7011). AB-FUBINACA (N-(1-amino-3-methyl-1-oxobutan- I 2-yl)-1-(4-fluorobenzyl)-1H-indazole-3- carboxamide) (7012). JWH-019 (1-Hexyl-3-(1-naphthoyl)indole) I (7019). AB-PINACA (N-(1 amino-3-methyl-1-oxobutan-2- I yl)-1-pentyl-1H-indazole-3-carboxamide) (7023). THJ-2201 [1-(5-fluoropentyl)-1H-indazol-3- I yl](naphthalene-1-yl)methanone (7024). AB-CHMINACA (N-(1-amino-3-methyl-1-oxobutan- I 2-yl)-1-(cyclohenxylmethyl)-1H-indazole-3- carboxamide (7031). ADB-PINACA (N-(1-amino-3,3-dimethyl-1- I oxobutan-2-yl)-1-pentyl-1H-indazole-3- carboxamide) (7035). APINACA and AKB48 N-(1-Adamantyl)-1-pentyl- I 1H-indazole-3-carboxamide (7048). JWH-081 (1-Pentyl-3-(1-(4- I methoxynaphthoyl)indole) (7081). SR-19 (Also known as RCS-4) (1-Pentyl-3-[(4- I methoxy)-benzoyl] indole (7104). JWH-018 (also known as AM678) (1-Pentyl-3-(1- I naphthoyl)indole) (7118). JWH-122 (1-Pentyl-3-(4-methyl-1- I naphthoyl)indole) (7122). UR-144 (1-Pentyl-1H-indol-3-yl)(2,2,3,3- I tetramethylcyclopropyl)methanone (7144). JWH-073 (1-Butyl-3-(1-naphthoyl)indole) I (7173). JWH-200 (1-[2-(4-Morpholinyl)ethyl]-3-(1- I naphthoyl) indole) (7200). AM-2201 (1-(5-Fluoropentyl)-3-(1- I naphthoyl)indole) (7201). JWH-203 (1-Pentyl-3-(2- I chlorophenylacetyl)indole) (7203). PB-22 (Quinolin-8-yl 1-pentyl-1H-indole-3- I carboxylate) (7222). 5F-PB-22 (Quinolin-8-yl 1-(5-fluoropentyl)- I 1H-indole-3-carboxylate) (7225). Alpha-ethyltryptamine (7249)................ I Ibogaine (7260)............................. I CP-47,497 (5-(1,1-Dimethylheptyl)-2-[(1R,3S)- I 3-hydroxycyclohexyl-phenol) (7297). CP-47,497 C8 Homologue (5-(1,1- I Dimethyloctyl)-2-[(1R,3S)3- hydroxycyclohexyl-phenol) (7298). Lysergic acid diethylamide (7315)........... I 2,5-Dimethoxy-4-(n)-propylthiophenethylamine I (2C-T-7) (7348). Marihuana (7360)............................ I Parahexyl (7374)............................ I Mescaline (7381)............................ I 2-(4-Elthylthio-2,5-dimethoxyphenyl) I ethanamine (2C-T-2) (7385). 3,4,5-Trimethoxyamphetamine (7390).......... I 4-Bromo-2,5-dimethoxyamphetamine (7391)..... I 4-Bromo-2,5-dimethoxyphenethylamine (7392).. I 4-Methyl-2,5-dimethoxyamphetamine (7395).... I 2,5-Dimethoxyamphetamine (7396)............. I JWH-398 (1-Pentyl-3-(4-chloro-1-naphthoyl) I indole (7398). 3,4-Methylenedioxyamphetamine (7400)........ I 5-Methoxy-3,4-methylenedioxyamphetamine I (7401). N-Hydroxy-3,4-methylenedioxyamphetamine I (7402). 3,4-Methylenedioxy-N-ethylamphetamine (7404) I 3,4-Methylenedioxymethamphetamine (7405).... I 4-Methoxyamphetamine (7411)................. I 5-Methoxy-N-N-dimethyltryptamine (7431)..... I Alpha-methyltryptamine (7432)............... I Bufotenine (7433)........................... I Diethyltryptamine (7434).................... I Dimethyltryptamine (7435)................... I Psilocybin (7437)........................... I Psilocyn (7438)............................. I 5-Methoxy-N,N-diisopropyltryptamine (7439).. I N-Ethyl-1-phenylcyclohexylamine (7455)...... I 1-(1-Phenylcyclohexyl)pyrrolidine (7458).... I 1-[1-(2-Thienyl)cyclohexyl]piperidine (7470) I N-Benzylpiperazine (7493)................... I 4-Methyl-alphapyrrolidinopropiophenone (4- I MePPP) (7498). 2-(2,5-Dimethoxy-4-methylphenyl) ethanamine I (2C-D) (7508). 2-(2,5-Dimethoxy-4-ethylphenyl) ethanamine I (2C-E) (7509). 2-(2,5-Dimethoxyphenyl) ethanamine (2C-H) I (7517). 2-(4-lodo-2,5-dimethoxyphenyl) ethanamine I (2C-I) (7518). 2-(4-Chloro-2,5-dimethoxyphenyl) ethanamine I (2C-C) (7519). 2-(2,5-Dimethoxy-4-nitro-phenyl) ethanamine I (2C-N) (7521). 2-(2,5-Dimethoxy-4-(n)-propylphenyl) I ethanamine (2C-P) (7524). 2-(4-Isopropylthio)-2,5-dimethoxyphenyl) I ethanamine (2C-T-4) (7532). MDPV (3,4-Methylenedioxypyrovalerone) (7535) I 2-(4-bromo-2,5-dimethoxyphenyl)-N-(2- I methoxybenzyl) ethanamine (25B-NBOMe) (7536). 2-(4-chloro-2,5-dimethoxyphenyl)-N-(2- I methoxybenzyl) ethanamine (25C-NBOMe) (7537). 2-(4-iodo-2,5-dimethoxyphenyl)-N-(2- I methoxybenzyl) ethanamine (25I-NBOMe) (7538). Methylone (3,4-Methylenedioxy-N- I methylcathinone) (7540). Butylone (7541)............................. I Pentylone (7542)............................ I alpha-pyrrolidinopentiophenone (a-PVP) I (7545). alpha-pyrrolidinobutiophenone (a-PBP) (7546) I AM-694 (1-(5-Fluoropentyl)-3-(2-iodobenzoyl) I indole) (7694). Desomorphine (9055)......................... I Etorphine (except HCI) (9056)............... I [[Page 15570]] Codeine methylbromide (9070)................ I Heroin (9200)............................... I Morphine-N-oxide (9307)..................... I Normorphine (9313).......................... I Pholcodine (9314)........................... I Acetylmethadol (9601)....................... I Allylprodine (9602)......................... I Alphacetylmethadol except levo- I alphacetylmethadol (9603). Alphameprodine (9604)....................... I Alphamethadol (9605)........................ I Betacetylmethadol (9607).................... I Betameprodine (9608)........................ I Betamethadol (9609)......................... I Betaprodine (9611).......................... I Dextromoramide (9613)....................... I Dipipanone (9622)........................... I Hydroxypethidine (9627)..................... I Noracymethadol (9633)....................... I Norlevorphanol (9634)....................... I Normethadone (9635)......................... I Racemoramide (9645)......................... I Trimeperidine (9646)........................ I 1-Methyl-4-phenyl-4-propionoxypiperidine I (9661). Tilidine (9750)............................. I Para-Fluorofentanyl (9812).................. I 3-Methylfentanyl (9813)..................... I Alpha-Methylfentanyl (9814)................. I Acetyl-alpha-methylfentanyl (9815).......... I Beta-hydroxyfentanyl (9830)................. I Beta-hydroxy-3-methylfentanyl (9831)........ I Alpha-methylthiofentanyl (9832)............. I 3-Methylthiofentanyl (9833)................. I Thiofentanyl (9835)......................... I Methamphetamine (1105)...................... II Methylphenidate (1724)...................... II Amobarbital (2125).......................... II Pentobarbital (2270)........................ II Secobarbital (2315)......................... II Glutethimide (2550)......................... II Nabilone (7379)............................. II 1-Phenylcyclohexylamine (7460).............. II Phencyclidine (7471)........................ II Phenylacetone (8501)........................ II 1-Piperidinocyclohexanecarbonitrile (8603).. II Alphaprodine (9010)......................... II Dihydrocodeine (9120)....................... II Ecgonine (9180)............................. II Ethylmorphine (9190)........................ II Levomethorphan (9210)....................... II Levorphanol (9220).......................... II Meperidine (9230)........................... II Dextropropoxyphene, bulk (non-dosage forms) II (9273). Levo-alphacetylmethadol (9648).............. II Noroxymorphone (9668)....................... II Racemethorphan (9732)....................... II Alfentanil (9737)........................... II Remifentanil (9739)......................... II Sufentanil (9740)........................... II Carfentanil (9743).......................... II Tapentadol (9780)........................... II ------------------------------------------------------------------------ The company plans to import small quantities of the listed controlled substances for the manufacture of analytical reference standards and distribution to their research and forensic customers. In reference to drug codes 7360 the company plans to import a synthetic cannabidiol. No other activity for this drug code is authorized for this registration. Placement of these drug codes onto the company's registration does not translate into automatic approval of subsequent permit applications to import controlled substances. Approval of permit applications will occur only when the registrant's business activity is consistent with what is authorized under to 21 U.S.C. 952(a)(2). Authorization will not extend to the import of FDA approved or non-approved finished dosage forms for commercial sale. [[Page 15571]] Dated: March 14, 2016. Louis J. Milione, Deputy Assistant Administrator. [FR Doc. 2016-06548 Filed 3-22-16; 8:45 am] BILLING CODE 4410-09-P
![15568 Federal Register / Vol. 81, No. 56 / Wednesday, March 23, 2016 / Notices
its customers. Dihydromorphine is an company’s compliance with state and SUMMARY: Cerilliant Corporation applied
intermediate in the manufacture of local laws, and reviewing the company’s to be registered as an importer of certain
Hydromorphone and is not for background and history. basic classes of controlled substances.
commercial distribution. Therefore, pursuant to 21 U.S.C. The Drug Enforcement Administration
Dated: March 14, 2016. 823(a), and in accordance with 21 CFR (DEA) grants Cerilliant Corporation
Louis J. Milione,
1301.33, the above-named company is registration as an importer of those
granted registration as a bulk controlled substances.
Deputy Assistant Administrator.
manufacturer of the following basic
[FR Doc. 2016–06532 Filed 3–22–16; 8:45 am] SUPPLEMENTARY INFORMATION: By notice
classes of controlled substances:
BILLING CODE 4410–09–P dated October 13, 2015, and published
Controlled substance Schedule in the Federal Register on October 21,
2015, 80 FR 63836, Cerilliant
DEPARTMENT OF JUSTICE Amphetamine (1100) .................... II
Corporation, 811 Paloma Drive, Suite A,
Lisdexamfetamine (1205) ............. II
Drug Enforcement Administration Methylphenidate (1724) ................ II Round Rock, Texas 78665–2402 applied
4-Anilino-N-phenethyl-4-piperidine II to be registered as an importer of certain
[Docket No. DEA–392]
(ANPP) (8333). basic classes of controlled substances.
Phenylacetone (8501) .................. II Comments and requests for hearing on
Manufacturer of Controlled Cocaine (9041) ............................. II
Substances Registration: Cambrex applications to import narcotic raw
Codeine (9050) ............................. II
Charles City Oxycodone (9143) ........................ II material are not appropriate. 72 FR
Hydromorphone (9150) ................ II 3417, (January 25, 2007). No comments
ACTION: Notice of registration. Hydrocodone (9193) ..................... II or objections were submitted for this
SUMMARY: Cambrex Charles City applied
Morphine (9300) ........................... II notice.
Oripavine (9330) ........................... II
to be registered as a manufacturer of Thebaine (9333) ........................... II The DEA has considered the factors in
certain basic classes of controlled Opium extracts (9610) .................. II 21 U.S.C. 823, 952(a) and 958(a) and
substances. The Drug Enforcement Opium fluid extract (9620) ............ II determined that the registration of
Administration (DEA) grants Cambrex Opium tincture (9630) .................. II Cerilliant Corporation to import the
Charles City registration as a Opium, powdered (9639) ............. II basic classes of controlled substances is
manufacturer of those controlled Oxymorphone (9652) ................... II
Noroxymorphone (9668) .............. II
consistent with the public interest and
substances. with United States obligations under
Fentanyl (9801) ............................ II
SUPPLEMENTARY INFORMATION: By notice international treaties, conventions, or
dated October 13, 2015, and published The company plans to manufacture protocols in effect on May 1, 1971. The
in the Federal Register on October 21, the listed controlled substances in bulk DEA investigated the company’s
2015, 80 FR 63835, Cambrex Charles for sale to its customers, for dosage form maintenance of effective controls
City, 1205 11th Street, Charles City, development, for clinical trials, and for against diversion by inspecting and
Iowa 50616 applied to be registered as use in stability qualification studies. testing the company’s physical security
a manufacturer of certain basic classes Dated: March 14, 2016. systems, verifying the company’s
of controlled substances. No other compliance with state and local laws,
Louis J. Milione,
comments or objections were submitted and reviewing the company’s
Deputy Assistant Administrator.
for this notice. background and history.
The DEA has considered the factors in [FR Doc. 2016–06536 Filed 3–22–16; 8:45 am]
21 U.S.C. 823(a) and determined that BILLING CODE 4410–09–P Therefore, pursuant to 21 U.S.C.
the registration of Cambrex Charles City 952(a) and 958(a), and in accordance
to manufacture the basic classes of with 21 CFR 1301.34, the above-named
controlled substances is consistent with DEPARTMENT OF JUSTICE company is granted registration as an
the public interest and with United importer of the following basic classes
Drug Enforcement Administration
States obligations under international of controlled substances:
treaties, conventions, or protocols in [Docket No. DEA–392]
effect on May 1, 1971. The DEA
investigated the company’s maintenance Importer of Controlled Substances
of effective controls against diversion by Registration: Cerilliant Corporation
inspecting and testing the company’s ACTION: Notice of registration.
physical security systems, verifying the
Controlled substance Schedule
3-Fluoro-N-methylcathinone (3–FMC) (1233) ............................................................................................................................................. I
Cathinone (1235) ......................................................................................................................................................................................... I
Methcathinone (1237) .................................................................................................................................................................................. I
4-Fluoro-N-methylcathinone (4–FMC) (1238) ............................................................................................................................................. I
Pentedrone (a-methylaminovalerophenone) (1246) .................................................................................................................................... I
Mephedrone (4-Methyl-N-methylcathinone) (1248) .................................................................................................................................... I
jstallworth on DSK7TPTVN1PROD with NOTICES
4-Methyl-N-ethylcathinone (4–MEC) (1249) ................................................................................................................................................ I
Naphyrone (1258) ........................................................................................................................................................................................ I
N-Ethylamphetamine (1475) ........................................................................................................................................................................ I
N,N-Dimethylamphetamine (1480) .............................................................................................................................................................. I
Fenethylline (1503) ...................................................................................................................................................................................... I
Methaqualone (2565) .................................................................................................................................................................................. I
JWH–250 (1-Pentyl-3-(2-methoxyphenylacetyl)indole) (6250) ................................................................................................................... I
SR–18 (Also known as RCS–8) (1-Cyclohexylethyl-3-(2-methoxyphenylacetyl)indole) (7008) ................................................................. I
VerDate Sep<11>2014 15:26 Mar 22, 2016 Jkt 238001 PO 00000 Frm 00071 Fmt 4703 Sfmt 4703 E:\FR\FM\23MRN1.SGM 23MRN1](https://thefederalregister.org/doc/81_FR_15624/page/1.svg)
methanone (7011) ................................ I
AB–FUBINACA (N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide) (7012) ..................................... I
JWH–019 (1-Hexyl-3-(1-naphthoyl)indole) (7019) ...................................................................................................................................... I
AB–PINACA (N-(1 amino-3-methyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide) (7023) .......................................................... I
THJ–2201 [1-(5-fluoropentyl)-1H-indazol-3-yl](naphthalene-1-yl)methanone (7024) ................................................................................. I
AB–CHMINACA (N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(cyclohenxylmethyl)-1H-indazole-3-carboxamide (7031) ............................... I
ADB–PINACA (N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide) (7035) ................................................. I
APINACA and AKB48 N-(1-Adamantyl)-1-pentyl-1H-indazole-3-carboxamide (7048) ............................................................................... I
JWH–081 (1-Pentyl-3-(1-(4-methoxynaphthoyl)indole) (7081) ................................................................................................................... I
SR–19 (Also known as RCS–4) (1-Pentyl-3-[(4-methoxy)-benzoyl] indole (7104) ..................................................................................... I
JWH–018 (also known as AM678) (1-Pentyl-3-(1-naphthoyl)indole) (7118) .............................................................................................. I
JWH–122 (1-Pentyl-3-(4-methyl-1-naphthoyl)indole) (7122) ...................................................................................................................... I
UR–144 (1-Pentyl-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)methanone (7144) ................................................................................. I
JWH–073 (1-Butyl-3-(1-naphthoyl)indole) (7173) ....................................................................................................................................... I
JWH–200 (1-[2-(4-Morpholinyl)ethyl]-3-(1-naphthoyl) indole) (7200) ......................................................................................................... I
AM–2201 (1-(5-Fluoropentyl)-3-(1-naphthoyl)indole) (7201) ...................................................................................................................... I
JWH–203 (1-Pentyl-3-(2-chlorophenylacetyl)indole) (7203) ....................................................................................................................... I
PB–22 (Quinolin-8-yl 1-pentyl-1H-indole-3-carboxylate) (7222) ................................................................................................................. I
5F–PB–22 (Quinolin-8-yl 1-(5-fluoropentyl)-1H-indole-3-carboxylate) (7225) ............................................................................................ I
Alpha-ethyltryptamine (7249) ...................................................................................................................................................................... I
Ibogaine (7260) ........................................................................................................................................................................................... I
CP–47,497 (5-(1,1-Dimethylheptyl)-2-[(1R,3S)-3-hydroxycyclohexyl-phenol) (7297) ................................................................................. I
CP–47,497 C8 Homologue (5-(1,1-Dimethyloctyl)-2-[(1R,3S)3-hydroxycyclohexyl-phenol) (7298) ........................................................... I
Lysergic acid diethylamide (7315) ............................................................................................................................................................... I
2,5-Dimethoxy-4-(n)-propylthiophenethylamine (2C–T–7) (7348) ............................................................................................................... I
Marihuana (7360) ........................................................................................................................................................................................ I
Parahexyl (7374) ......................................................................................................................................................................................... I
Mescaline (7381) ......................................................................................................................................................................................... I
2-(4-Elthylthio-2,5-dimethoxyphenyl) ethanamine (2C–T–2) (7385) ........................................................................................................... I
3,4,5-Trimethoxyamphetamine (7390) ........................................................................................................................................................ I
4-Bromo-2,5-dimethoxyamphetamine (7391) .............................................................................................................................................. I
4-Bromo-2,5-dimethoxyphenethylamine (7392) .......................................................................................................................................... I
4-Methyl-2,5-dimethoxyamphetamine (7395) .............................................................................................................................................. I
2,5-Dimethoxyamphetamine (7396) ............................................................................................................................................................ I
JWH–398 (1-Pentyl-3-(4-chloro-1-naphthoyl) indole (7398) ....................................................................................................................... I
3,4-Methylenedioxyamphetamine (7400) .................................................................................................................................................... I
5-Methoxy-3,4-methylenedioxyamphetamine (7401) .................................................................................................................................. I
N-Hydroxy-3,4-methylenedioxyamphetamine (7402) .................................................................................................................................. I
3,4-Methylenedioxy-N-ethylamphetamine (7404) ........................................................................................................................................ I
3,4-Methylenedioxymethamphetamine (7405) ............................................................................................................................................ I
4-Methoxyamphetamine (7411) ................................................................................................................................................................... I
5-Methoxy-N–N-dimethyltryptamine (7431) ................................................................................................................................................. I
Alpha-methyltryptamine (7432) ................................................................................................................................................................... I
Bufotenine (7433) ........................................................................................................................................................................................ I
Diethyltryptamine (7434) ............................................................................................................................................................................. I
Dimethyltryptamine (7435) .......................................................................................................................................................................... I
Psilocybin (7437) ......................................................................................................................................................................................... I
Psilocyn (7438) ............................................................................................................................................................................................ I
5-Methoxy-N,N-diisopropyltryptamine (7439) .............................................................................................................................................. I
N-Ethyl-1-phenylcyclohexylamine (7455) .................................................................................................................................................... I
1-(1-Phenylcyclohexyl)pyrrolidine (7458) .................................................................................................................................................... I
1-[1-(2-Thienyl)cyclohexyl]piperidine (7470) ............................................................................................................................................... I
N-Benzylpiperazine (7493) .......................................................................................................................................................................... I
4-Methyl-alphapyrrolidinopropiophenone (4-MePPP) (7498) ...................................................................................................................... I
2-(2,5-Dimethoxy-4-methylphenyl) ethanamine (2C–D) (7508) .................................................................................................................. I
2-(2,5-Dimethoxy-4-ethylphenyl) ethanamine (2C–E) (7509) ..................................................................................................................... I
2-(2,5-Dimethoxyphenyl) ethanamine (2C–H) (7517) ................................................................................................................................. I
2-(4-lodo-2,5-dimethoxyphenyl) ethanamine (2C–I) (7518) ........................................................................................................................ I
2-(4-Chloro-2,5-dimethoxyphenyl) ethanamine (2C–C) (7519) ................................................................................................................... I
2-(2,5-Dimethoxy-4-nitro-phenyl) ethanamine (2C–N) (7521) .................................................................................................................... I
2-(2,5-Dimethoxy-4-(n)-propylphenyl) ethanamine (2C–P) (7524) ............................................................................................................. I
2-(4-Isopropylthio)-2,5-dimethoxyphenyl) ethanamine (2C–T–4) (7532) .................................................................................................... I
MDPV (3,4-Methylenedioxypyrovalerone) (7535) ....................................................................................................................................... I
2-(4-bromo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl) ethanamine (25B–NBOMe) (7536) .................................................................... I
2-(4-chloro-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl) ethanamine (25C–NBOMe) (7537) ..................................................................... I
2-(4-iodo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl) ethanamine (25I–NBOMe) (7538) ......................................................................... I
jstallworth on DSK7TPTVN1PROD with NOTICES
Methylone (3,4-Methylenedioxy-N-methylcathinone) (7540) ....................................................................................................................... I
Butylone (7541) ........................................................................................................................................................................................... I
Pentylone (7542) ......................................................................................................................................................................................... I
alpha-pyrrolidinopentiophenone (a-PVP) (7545) ......................................................................................................................................... I
alpha-pyrrolidinobutiophenone (a-PBP) (7546) ........................................................................................................................................... I
AM–694 (1-(5-Fluoropentyl)-3-(2-iodobenzoyl) indole) (7694) .................................................................................................................... I
Desomorphine (9055) .................................................................................................................................................................................. I
Etorphine (except HCI) (9056) .................................................................................................................................................................... I
VerDate Sep<11>2014 15:26 Mar 22, 2016 Jkt 238001 PO 00000 Frm 00072 Fmt 4703 Sfmt 4703 E:\FR\FM\23MRN1.SGM 23MRN1](https://thefederalregister.org/doc/81_FR_15624/page/2.svg)
![Federal Register / Vol. 81, No. 56 / Wednesday, March 23, 2016 / Notices 15571
Dated: March 14, 2016. DEPARTMENT OF LABOR Constitution Avenue NW., Washington,
Louis J. Milione, DC 20210; telephone (202) 693–1999;
Deputy Assistant Administrator. Occupational Safety and Health email jameson.grettah@dol.gov.
[FR Doc. 2016–06548 Filed 3–22–16; 8:45 am] Administration Instructions: Your submissions must
BILLING CODE 4410–09–P
include the agency name and docket
[Docket No. OSHA–2016–0008]
number for this Federal Register notice
Whistleblower Protection Advisory (Docket No. OSHA–2016–0008). Due to
DEPARTMENT OF JUSTICE Committee (WPAC) security-related procedures,
submissions by regular mail may
Drug Enforcement Administration AGENCY: Occupational Safety and Health experience significant delays. Please
[Docket No. DEA–392]
Administration (OSHA), Labor. contact the OSHA Docket Office for
ACTION: Announcement of a meeting of information about security procedures
Bulk Manufacturer of Controlled WPAC. for making submissions. For additional
Substances Application: Patheon information on submitting comments,
Pharmaceuticals, Inc. SUMMARY: WPAC will meet April 26, requests to speak, and speaker
2016, in Washington, DC. presentations, see the SUPPLEMENTARY
ACTION: Notice of application. DATES: WPAC meeting: WPAC will meet INFORMATION section of this notice.
from 9:00 a.m. to 4:00 p.m., E.T., FOR FURTHER INFORMATION CONTACT:
DATES: Registered bulk manufacturers of Tuesday, April 26, 2015. For press inquiries: Mr. Frank
the affected basic class, and applicants Written comments, requests to speak, Meilinger, Director, OSHA Office of
therefore, may file written comments on speaker presentations, and requests for Communications, Room N–3647, U.S.
or objections to the issuance of the special accommodation: You must Department of Labor, 200 Constitution
proposed registration in accordance Avenue NW., Washington, DC 20210;
submit (postmark, send, transmit)
with 21 CFR 1301.33(a) on or before telephone (202) 693–1999; email
comments, requests to address the
May 23, 2016. meilinger.francis2@dol.gov.
WPAC meeting, speaker presentations
ADDRESSES: Written comments should (written or electronic), and requests for For general information about WPAC
be sent to: Drug Enforcement special accommodations for the WPAC and WPAC meetings: Mr. Anthony Rosa,
Administration, Attention: DEA Federal meeting by April 12, 2016. OSHA, Directorate of Whistleblower
Register Representative/ODW, 8701 Protection Programs, Room N–4618,
ADDRESSES: WPAC meeting: WPAC will
Morrissette Drive, Springfield, Virginia U.S. Department of Labor, 200
22152. meet in Room N–4437 A–C, U.S.
Department of Labor, Francis Perkins Constitution Avenue NW., Washington,
SUPPLEMENTARY INFORMATION: The Building, 200 Constitution Avenue NW., DC 20210; telephone (202) 693–2199;
Attorney General has delegated her Washington, DC 20210. email osha.dwpp@dol.gov.
authority under the Controlled Submission of comments, requests to SUPPLEMENTARY INFORMATION:
Substances Act to the Administrator of speak, and speaker presentations: You
the Drug Enforcement Administration WPAC Meeting
may submit comments, requests to
(DEA), 28 CFR 0.100(b). Authority to speak at the WPAC meeting, and WPAC will meet Tuesday, April 26,
exercise all necessary functions with speaker presentations using one of the 2015, in Washington, DC. WPAC
respect to the promulgation and following methods: meetings are open to the public.
implementation of 21 CFR part 1301, The tentative agenda of the WPAC
Electronically: You may submit
incident to the registration of meeting includes:
materials, including attachments,
manufacturers, distributors, dispensers, electronically at http:// Remarks from the Assistant Secretary of
importers, and exporters of controlled www.regulations.gov, which is the Labor for Occupational Safety and Health
substances (other than final orders in Federal eRulemaking Portal. Follow the (OSHA);
connection with suspension, denial, or on-line instructions for submissions.
Remarks from the Director of the Directorate
revocation of registration) has been of Whistleblower Protection Programs;
Facsimile (Fax): If your submission, Presentations from other federal agencies
redelegated to the Deputy Assistant including attachments, does not exceed
Administrator of the DEA Office of with whistleblower programs;
10 pages, you may fax it to the OSHA Railroad worker whistleblower presentation;
Diversion Control (‘‘Deputy Assistant
Docket Office at (202) 693–1648. Public comments;
Administrator’’) pursuant to section 7 of
Regular mail, express mail, hand Work Group presentations; and,
28 CFR part 0, appendix to subpart R. Old business.
delivery, or messenger (courier) service:
In accordance with 21 CFR
You may submit your materials to the OSHA transcribes WPAC meetings and
1301.33(a), this is notice that on
OSHA Docket Office, Docket No. prepares detailed minutes of the
December 10, 2015, Patheon
OSHA–2016–0008, Room N–2625, U.S. meetings. OSHA places the meeting
Pharmaceuticals, Inc., 2110 E. Galbraith
Department of Labor, 200 Constitution transcripts and minutes in the public
Road, Cincinnati, Ohio 45237 applied to
Avenue NW., Washington, DC 20210; record of the WPAC meeting. The public
be registered as a bulk manufacturer of
telephone (202) 693–2350 (TTY (877) record also includes Work Group
gamma hydroxybutyric acid (2010) a
889–5627). OSHA’s Docket Office reports, speaker presentations,
basic class of controlled substance listed
accepts deliveries (hand deliveries, comments and other materials
in schedule I.
The company plans to manufacture express mail, and messenger service) submitted to WPAC.
during normal business hours, 8:15
jstallworth on DSK7TPTVN1PROD with NOTICES
the listed controlled substance for WPAC Work Groups
product development. a.m.–4:45 p.m., E.T., weekdays.
Requests for special accommodations: The WPAC work groups (Outreach
Dated: March 14, 2016. Please submit any requests for special and Training) will meet on April 25,
Louis J. Milione, accommodations to attend the WPAC 2016. These work group meetings will
Deputy Assistant Administrator. meeting to Ms. Gretta Jameson, OSHA, be open to the public. The purpose of
[FR Doc. 2016–06539 Filed 3–22–16; 8:45 am] Office of Communications, Room N– the work groups is to provide
BILLING CODE 4410–09–P 3647, U.S. Department of Labor, 200 recommendations to the full WPAC
VerDate Sep<11>2014 15:26 Mar 22, 2016 Jkt 238001 PO 00000 Frm 00074 Fmt 4703 Sfmt 4703 E:\FR\FM\23MRN1.SGM 23MRN1](https://thefederalregister.org/doc/81_FR_15624/page/4.svg)
Document Created: 2016-03-23 00:03:08
Document Modified: 2016-03-23 00:03:08
| Category | Regulatory Information | |
| Collection | Federal Register | |
| sudoc Class | AE 2.7: GS 4.107: AE 2.106: | |
| Publisher | Office of the Federal Register, National Archives and Records Administration | |
| Section | Notices | |
| Action | Notice of registration. | |
| FR Citation | 81 FR 15568 |
2025 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR